Limited window for donation of convalescent plasma with high live-virus neutralizing antibodies for COVID-19 immunotherapy
A. Gontu, S. Srinivasan, E. Salazar, M. Surendran Nair, R. H. Nissly, D. Greenawalt, I. M. Bird, C. Herzog, M. J. Ferrari, I. Poojary, R. Katani, S. E. Lindner, A. M. Minns, R. Rossi, P. A. Christensen, , S. V. Kuchipudi
The study evaluates anti-SARS-CoV-2 antibody and neutralizing titer profiles in convalescent plasma samples to determine the optimal donation window for immunotherapy.
bioRxiv · Aug 21, 2020Immunology